Targeting Long Prolactin Receptor Isoforms Curbs Lupus Damage in Preclinical Study
Researchers have developed splice-modulating oligomers that selectively suppress long-form prolactin receptors, reducing harmful immune cells and kidney damage in preclinical ...

